Wolverine Trading’s Achillion Pharmaceuticals ACHN Stock Holding History

Wolverine Trading’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-25,500	Closed	-$94K	–	5523
2019 Q3	$94K	Buy	+25,500	New	+$98.3K	﹤0.01%	3872
2018 Q4	–	Sell	-25,200	Closed	-$93K	–	5771
2018 Q3	$93K	Buy	25,200 +5,900	+31%	+$17.6K	﹤0.01%	4566
2018 Q2	$72K	Hold	19,300	–	–	﹤0.01%	4831
2018 Q1	$72K	Sell	19,300 -10,600	-35%	-$34.7K	﹤0.01%	4831
2017 Q4	$86K	Sell	29,900 -6,300	-17%	-$22.9K	﹤0.01%	4493
2017 Q3	$163K	Sell	36,200 -5,400	-13%	-$24K	﹤0.01%	3913
2017 Q2	$187K	Buy	41,600 +5,300	+15%	+$21.3K	﹤0.01%	3636
2017 Q1	$155K	Buy	+36,300	New	+$151K	﹤0.01%	3675
2016 Q3	–	Sell	-129,500	Closed	-$1.01M	–	5338
2016 Q2	$1.01M	Buy	+129,500	New	+$1.11M	0.01%	1581

Wolverine Trading's ACHN Position: Q4 2019 in Review

Wolverine Trading sold out of Achillion Pharmaceuticals (ACHN) in Q4 2019, closing a stake of 25,070 shares — an estimated $145K sold.

Wolverine Trading first reported a position in ACHN in Q1 2018 and held it in 3 quarters. The position peaked at $104K in Q2 2018. 132 funds tracked by Wall St. Rank hold ACHN as of Q4 2019.

Wolverine Trading reported no remaining Achillion Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Wolverine Trading sold 25,070 Achillion Pharmaceuticals shares in Q4 2019, an estimated $145K.
Wolverine Trading first reported a position in Achillion Pharmaceuticals in Q1 2018 and held it in 3 quarters.
Wolverine Trading's Achillion Pharmaceuticals position peaked at $104K in Q2 2018.
132 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2019.

Based on Wolverine Trading's 13F filing for Q4 2019, filed 12 Feb 2020.